YOUNG KYUNG PARK;YOUNG JIN PARK;SUNG YOUB JUNG;MYUNG HYUN JANG;HANMI SCIENCE CO. LTD.;LING AI SHEN;SE CHANG KWON
发明人:
SE CHANG KWON,SUNG YOUB JUNG,YOUNG JIN PARK,MYUNG HYUN JANG,LING AI SHEN,YOUNG KYUNG PARK
申请号：
IL26058218
公开号：
IL260582A
申请日:
2018.07.12
申请国别(地区):
IL
年份:
2019
代理人:
摘要：
The present invention relates to a novel peptide showing more excellent activities on a glucagon like peptide-1 receptor and a glucagon receptor than native oxyntomodulin, and a composition for the prevention or treatment of obesity comprising the peptide as an active ingredient. Unlike native oxyntomodulin, the novel peptide of the present invention reduces food intake, suppresses gastric emptying, and facilitates lipolysis with reduced side-effects, and also shows excellent receptor-activating effects. Thus, it can be widely used in the treatment of obesity with safety and efficacy.
